Article

A Neurotoxin With Many Uses


 

Headache Pain
Botulinum toxin can be and is used for headache. “Let me emphasize it is off label, at least for now. I would describe it as very controversial,” Dr. Ward said. “There is good evidence that it does not work for tension-type headache.” Conflicting evidence exists regarding other headache types. It may be effective in chronic migraine if the patients are not on preventive treatments. “There is an [American Academy of Neurology] assessment that basically outlines what it thinks are the flaws in the evidence—that it doesn’t work for tension-type headache, that maybe it works in some cases in some types of migraine—and I would recommend that you read that because it is evidence based.”

—Glenn S. Williams

Suggested Reading
Dodick DW, Turkel CC, Degryse RE, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010 May 17; [Epub ahead of print].

Naumann M, So Y, Argoff CE, et al. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;70(19):1707-1709.

Simpson DM, Blitzer A, Brashear A, et al. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;70(19):1699-1706.

Simpson DM, Gracies JM, Graham HK, et al. Assessment: Botulinum neurotoxin in the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;70(19):1691-1698.

Pages

Recommended Reading

PD Outcomes No Better With Early Treatment
MDedge Neurology
Be Proactive in Treating Parkinson's Dementia
MDedge Neurology
Protein Aggregation May Drive PD Development, Progression
MDedge Neurology
Dopamine Agonists, L-Dopa Have Trade-Offs
MDedge Neurology
Latrepirdine Improved Cognitive Symptoms in Huntington's
MDedge Neurology
Gene Therapy Reduced L-Dopa–Induced Dyskinesia
MDedge Neurology
REM Sleep Behavior Disorder May Portend Impairments
MDedge Neurology
New Guidelines Are Issued for Four Nonmotor PD Symptoms
MDedge Neurology
PPN Stimulation Controls Parkinsonian Sleepiness
MDedge Neurology
New Algorithm Helps to Differentiate Early-Stage Parkinsonian Disorders
MDedge Neurology